C. Cellerai

Discipline

Anthropologie biologique (1)

Type de document

Articles (11)

Co-auteur

Date

Source

Mot-clé

Treatment (8) thérapie (7) Therapeutics (7) virus (6) temps (durée) (5) Time (5) Patients (5) Patients (5) Methods (4) Immunodeficiency (4) Swiss (4) Human beings (4) Impact (4) Examinations (4) Drug resistance (4) Methods (4) risque (3) association (3) infection (3) effet (3) Control (3) Year (3) Social groups (3) Risk (3) RNA (3) Infection (3) Models (3) cohorte (3) résistance (3) spectacle (2)

Documents écrit par C. Cellerai (11) | parle de C. Cellerai (0)

Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.
N. Ngo-Giang-Huong et al. (8 nov. 2016)
Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell Responses.
S. Kinloch-de Loes et al. (2015)
Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay.
A. Mühlbacher et al. (2013)
The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients.
N. Beerenwinkel et al. (2013)
Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-specific CD8 T Cells.
S. Viganò et al. (2013)
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
A.U. Scherrer et al. (2012)
Inferring epidemic contact structure from phylogenetic trees.
G.E. Leventhal et al. (2012)
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.
V. von Wyl et al. (2012)
HIV Testing Practices by Clinical Service before and after Revised Testing Guidelines in a Swiss University Hospital
O. Hugli et al. (2012)
Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors.
C. Cellerai et al. (2011)
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
A. Harari et al. (2008)